Barclays’s WebMD Health Corp. WBMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-31,663
Closed -$1.86M 7255
2017
Q2
$1.86M Buy
31,663
+8,464
+36% +$472K ﹤0.01% 2326
2017
Q1
$1.22M Buy
23,199
+20,485
+755% +$1.05M ﹤0.01% 2555
2016
Q4
$134K Sell
2,714
-10,997
-80% -$569K ﹤0.01% 4542
2016
Q3
$681K Sell
13,711
-36,609
-73% -$2.02M ﹤0.01% 2976
2016
Q2
$2.92M Sell
50,320
-20,621
-29% -$1.29M ﹤0.01% 1713
2016
Q1
$4.4M Buy
70,941
+36,613
+107% +$1.96M 0.01% 1283
2015
Q4
$1.65M Buy
34,328
+29,882
+672% +$1.33M ﹤0.01% 2175
2015
Q3
$174K Sell
4,446
-10,148
-70% -$429K ﹤0.01% 4233
2015
Q2
$642K Sell
14,594
-29,956
-67% -$1.37M ﹤0.01% 3264
2015
Q1
$1.92M Buy
44,550
+389
+0.9% +$16.2K ﹤0.01% 2364
2014
Q4
$1.72M Buy
44,161
+8,285
+23% +$318K ﹤0.01% 2664
2014
Q3
$1.47M Sell
35,876
-46,661
-57% -$2.25M ﹤0.01% 2954
2014
Q2
$3.96M Sell
82,537
-3,550
-4% -$155K ﹤0.01% 1967
2014
Q1
$3.53M Buy
86,087
+23,479
+38% +$1.06M ﹤0.01% 2008
2013
Q4
$2.44M Buy
62,608
+2,735
+5% +$98.7K ﹤0.01% 2462
2013
Q3
$1.68M Sell
59,873
-32,462
-35% -$1.01M ﹤0.01% 2794
2013
Q2
$2.71M Buy
+92,335
New +$2.47M ﹤0.01% 2212

Other funds holding WBMD

Barclays's WBMD Position: Q3 2017 in Review

Barclays sold out of WebMD Health Corp. (WBMD) in Q3 2017, closing a stake of 31,663 shares — an estimated $1.86M sold.

Barclays first reported a position in WBMD in Q2 2013 and held it in 17 quarters. The position peaked at $4.4M in Q1 2016. 1 fund tracked by Wall St. Rank holds WBMD as of Q3 2017.

  • Barclays reported no remaining WebMD Health Corp. position as of Q3 2017 after selling out during the quarter.
  • Barclays sold 31,663 WebMD Health Corp. shares in Q3 2017, an estimated $1.86M.
  • Barclays first reported a position in WebMD Health Corp. in Q2 2013 and held it in 17 quarters.
  • Barclays's WebMD Health Corp. position peaked at $4.4M in Q1 2016.
  • 1 fund tracked by Wall St. Rank held WebMD Health Corp. as of Q3 2017.

Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.